These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4040315)

  • 1. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T; Maruta H; Ito N
    Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
    Saito M; Masaki T; Kato H; Numasaka K
    Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypomagnesemia following chemotherapy of disseminated testicular tumors].
    Hida S; Nishimura K; Nishio Y; Okada Y; Okada K; Yoshida O
    Hinyokika Kiyo; 1988 Jan; 34(1):52-60. PubMed ID: 2454015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
    Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
    Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of CDDP in the treatment of patients with gastric and esophageal cancers, with special reference to the evaluation of renal functions before and after CDDP administration].
    Sasaki E; Namatame K; Hirose C; Hamai N; Onomura Y; Miyata N; Kusumoto S; Makuuchi M; Iwai H; Asakawa K
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2713-7. PubMed ID: 3415269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
    Yogi S; Ikeuchi T; Kai Y
    Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
    Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of metastatic urothelial carcinoma. cis-Diamminedichloroplatinum combination chemotherapy for patients with decreased renal function].
    Kihara K; Kusuyama H; Washizuka M; Kawai T
    Hinyokika Kiyo; 1984 Jan; 30(1):21-8. PubMed ID: 6539559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Definitive end-stage chronic kidney failure after cisplatin treatment].
    Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
    Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):888-96. PubMed ID: 4040542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
    Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin nephrotoxicity: experimental and clinical studies.
    Daugaard G
    Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.